Press Releases

23.04.2018

The biopharmaceutical company MOLOGEN AG announced today the new dates for the publication of the Annual Financial Statements 2017 on 25 April 2018 and the holding of the Annual General Meeting on 8 June 2018.

20.04.2018

The biopharmaceutical company MOLOGEN AG announced today that the collaboration with ONCOLOGIE, agreed on in February 2018, is making good progress.

19.04.2018

Berlin, 19 April 2018 – The biopharmaceutical company MOLOGEN AG presented data of its EnanDIM® molecules, a new generation of potent non chemically-modified TLR9 agonists, at the AACR Annual Meeting 2018 (American Association for Cancer Research)...

09.04.2018

Berlin, 9 April 2018 – The biopharmaceutical company MOLOGEN AG will present a poster at the AACR Annual Meeting 2018 (American Association for Cancer Research) in Chicago, Illinois, U.S. (14 – 18 April 2018).

06.04.2018

Berlin, 6 April 2018 – The biopharmaceutical company MOLOGEN AG announced that the final evaluation of the randomized exploratory phase II IMPULSE study confirmed the findings presented in April 2017 and at the ESMO conference in September 2017.

   

Displaying results 1 bis 7 von 10

Page 1

Page 2

next

   

Contact:
Claudia Nickolaus
Head of Investor Relations & Corporate Communications

T. +49 (0) 30 - 84 17 88 - 86
F. +49 (0) 30 - 84 17 88 - 50

investor@mologen.com

Distribution list

If you would like to receive our press releases, please click here.